| Managing clinical grant costs. | |
| | |
MedLine Citation:
|
PMID: 19470309 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The rapidly increasing cost of pharmaceutical R&D presents a major challenge for the industry. This paper examines one aspect of that spending, clinical grants, and presents ways that pharmaceutical companies can best manage those expenditures. The first part of the paper examines the role of clinical grant payments as a motivation for clinical trial participation. The second part outlines a number of current management practices for controlling clinical grant costs. Financial compensation is an important matter for many physicians conducting clinical trials, especially those in office-based practices and those conducting phase 4 clinical trials. Since financial considerations are important to most types of investigators, and there is no compelling evidence that paying at high rates insures timely performance or quality data, companies engaging clinical investigators must manage their clinical grant funds as effectively as possible. Sound financial management requires that clinical development professionals appreciate the complex relationship between the pharmaceutical company and the physicians who serve as clinical investigators on that company's clinical trials. Sensible financial management of clinical grants also demands that sponsor companies get the most value for their clinical grant spending. Ultimately, good clinical grant management requires an attitude that combines good business sense with an understanding that pharmaceutical R&D strives to bring to market new drugs that can help patient populations around the world. Investigators are medical contractors in clinical trials, and while they are engaged in their vital research, they are a part of the research process that must be carefully budgeted and managed. Society, pharmaceutical companies, clinical investigators, and patients will reap the benefits of adequately budgeted, and well managed clinical grants. |
| | |
Authors:
|
Harold E Glass; Karen Hollander |
Related Documents
:
|
21607209 - Sam acute medicine trainees skills survey 2009. 22002779 - Competency in musculoskeletal and sports medicine: evaluating a pgy-1 curriculum. 12812409 - Peripheral neuropathies in clinical practice. 16372789 - A span of control tool for clinical managers. 21730769 - Robotic health assistant (feverkit) for the rational management of fevers among nomads ... 17948839 - Managed clinical networks: what are they and how do they work? 21879009 - Healthcare liquid waste management. 20372689 - Practice management - tips from the toolkit: 3 governance. 1556539 - Where are articles by candidates for academic promotion published? |
Publication Detail:
|
Type: Journal Article Date: 2009-02-12 |
Journal Detail:
|
Title: Contemporary clinical trials Volume: 30 ISSN: 1559-2030 ISO Abbreviation: Contemp Clin Trials Publication Date: 2009 May |
Date Detail:
|
Created Date: 2009-11-03 Completed Date: 2010-02-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101242342 Medline TA: Contemp Clin Trials Country: United States |
Other Details:
|
Languages: eng Pagination: 221-6 Citation Subset: IM |
Affiliation:
|
University of the Sciences in Philadelphia, Philadelphia, PA 19104, USA. h.glass@usp.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Budgets Clinical Trials as Topic / economics* Cost Control / methods Drug Industry / economics* Health Expenditures* Humans Questionnaires Research Personnel / economics Research Support as Topic / economics* United States |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Acquiring allergen information from condom manufacturers: a questionnaire survey.
Next Document: A novel diagram and complement to the CONSORT chart for presenting multimodal clinical trials.